Personalized Immunotherapeutic for Antibiotic-resistant Infection

NCT02508584 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
1
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Brigham and Women's Hospital